@misc{oai:repo.qst.go.jp:00063839,
 author = {服部, 聡子 and 丸山, 将浩 and 関, 千江 and 季, 斌 and 前田, 純 and 岡内, 隆 and 樋口, 真人 and 須原, 哲也 and その他 and 服部 聡子 and 丸山 将浩 and 関 千江 and 季 斌 and 前田 純 and 岡内 隆 and 樋口 真人 and 須原 哲也},
 month = {Sep},
 note = {Positron emission tomography (PET) has been conducted in patients with neurodegenerative diseases, but the neuropathological basis of the PET findings remains elusive, due to the lack of animals modeling the chronic, progressive neurodegeneration. Here, we performed combined microPET and histological examinations of tau transgenic mice showing age-dependent deteriorations leading to massive neuronal loss. The cerebral glucose utilization measured by [18F]fluorodeoxyglucose and neuroinflammation quantified by a radioligand for translocator proteins (TSPOs) were positively correlated with the number of neurons and magnitude of gliosis, respectively. The TSPO upregulation was noticeable in brains with minimal atrophies, supporting its significance as an early pathological marker. Meanwhile, the glucose hypometabolism was linearly proportional to the loss of neurons, and thus can be an index reflecting the severity of the neurodegeneration., 第32回日本神経科学大会},
 title = {PETによるタウオパチーモデルマウス神経変性病理の検出},
 year = {2009}
}